What is Spark Biomedical?
Founded in 2018, Spark Biomedical operates at the intersection of medical technology and neurology. The company is recognized for developing the first personalized, wearable neurostimulation solution specifically engineered to provide relief from opioid withdrawal symptoms. By utilizing data derived from double-blind, randomized controlled clinical trials, the firm has established a robust clinical foundation for its proprietary technology. This focus on evidence-based medicine distinguishes Spark Biomedical within the competitive landscape of digital health and neuro-modulation, positioning it as a leader in addressing the opioid use disorder crisis through innovative, non-invasive hardware solutions.
How much funding has Spark Biomedical raised?
Spark Biomedical has raised a total of $31.2M across 2 funding rounds:
Other Financing Round
$16.2M
Series A
$15M
Other Financing Round (2023): $16.2M, investors not publicly disclosed
Series A (2025): $15M led by Pathway To Cures and WAVE Ventures
Key Investors in Spark Biomedical
Pathway To Cures
A mission-driven investment organization focused on accelerating the development of transformative therapies for patients with unmet medical needs.
WAVE Ventures
A venture capital firm specializing in early-stage investments within the healthcare and life sciences sectors, prioritizing high-impact medical innovations.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Spark Biomedical?
Looking ahead, the recent capital infusion will likely be directed toward scaling manufacturing capabilities and broadening the clinical application of its wearable neurostimulation platform. As the company transitions from its initial development phase into a more mature commercialization stage, the focus will shift toward securing broader regulatory approvals and expanding its footprint within the healthcare provider network. The strategic backing received will be instrumental in navigating the complexities of the medical device market, ensuring that Spark Biomedical can effectively deliver its therapeutic solutions to a wider patient demographic while maintaining the rigorous clinical standards that define its brand identity.
See full Spark Biomedical company page
